177 related articles for article (PubMed ID: 10707797)
21. Therapy of advanced-stage mature B-cell lymphoma and leukemia in children and adolescents with rituximab and reduced intensity induction chemotherapy (B-NHL 2004M protocol): the results of a multicenter study.
Samochatova EV; Maschan AA; Shelikhova LN; Myakova NV; Belogurova MB; Khlebnikova OP; Shamardina AV; Ryskal OV; Roumiantseva JV; Konovalov DM; Dubrovina ME; Rumyantsev AG
J Pediatr Hematol Oncol; 2014 Jul; 36(5):395-401. PubMed ID: 23823112
[TBL] [Abstract][Full Text] [Related]
22. Intensive chemotherapy without radiotherapy gives more than 85% event-free survival for non-Hodgkin lymphoma without central nervous involvement: a 6-year population-based study from the nordic society of pediatric hematology and oncology.
Márky I; Björk O; Forestier E; Jónsson OG; Perkkiö M; Schmiegelow K; Storm-Mathiesen I; Gustafsson G;
J Pediatr Hematol Oncol; 2004 Sep; 26(9):555-60. PubMed ID: 15342981
[TBL] [Abstract][Full Text] [Related]
23. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Münster Group Trial NHL-BFM 90.
Seidemann K; Tiemann M; Schrappe M; Yakisan E; Simonitsch I; Janka-Schaub G; Dörffel W; Zimmermann M; Mann G; Gadner H; Parwaresch R; Riehm H; Reiter A
Blood; 2001 Jun; 97(12):3699-706. PubMed ID: 11389005
[TBL] [Abstract][Full Text] [Related]
24. A cooperative study of epirubicin with cyclophosphamide, vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma.
Lambertenghi Deliliers G; Butti C; Baldini L; Ceriani A; Lombardi F; Luoni M; Montalbetti L; Pavia G; Pinotti G; Pogliani E
Haematologica; 1995; 80(4):318-24. PubMed ID: 7590500
[TBL] [Abstract][Full Text] [Related]
25. Immunodeficiency and Hodgkin's disease: treatment and outcome in the DAL HD78-90 and GPOH HD95 studies.
Niehues T; Schellong G; Dörffel W; Bucsky P; Mann G; Körholz D; Göbel U
Klin Padiatr; 2003; 215(6):315-20. PubMed ID: 14677095
[TBL] [Abstract][Full Text] [Related]
26. [Hungarian experience with non-Hodgkin's lymphoma in childhood].
Müller J; Csóka M; Jakab Z; Ponyi A; Erlaky H; Kovács G
Magy Onkol; 2006; 50(3):253-9. PubMed ID: 17099787
[TBL] [Abstract][Full Text] [Related]
27. Treatment results of the TPOG-NHL92 protocols for childhood non-Hodgkin's lymphomas in Taiwan: a report from the Taiwan Pediatric Oncology Group (TPOG).
Yang CP; Hung JJ; Jaing TH; Lin KH; Lin DT; Lu MY; Liang DC; Chen SH; Liu HC; Hsiao CC; Shu SG; Chen JS; Chang TT; Chiou SS; Hsieh YL; Lin MT; Lee MT; Peng CT; Cheng SN; Chen RL; Chen BW; Lin KS
Acta Paediatr Taiwan; 2000; 41(4):193-204. PubMed ID: 11021005
[TBL] [Abstract][Full Text] [Related]
28. Improved treatment outcome in Chinese children and adolescents with Burkitt's lymphoma and large cell lymphoma by using the modified B-non-Hodgkin's lymphoma-Berlin-Frankfurt-Münster-90 protocol.
Sun XF; Zhen ZJ; Lui DG; Xia Y; He YJ; Wang ZH; Lin JY; Guan ZZ
Eur J Haematol; 2006 Nov; 77(5):365-71. PubMed ID: 16879606
[TBL] [Abstract][Full Text] [Related]
29. Non-Hodgkin's lymphoma associated with the acquired immunodeficiency syndrome.
Cáceres W
Bol Asoc Med P R; 1995; 87(10-12):158-61. PubMed ID: 8924158
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
31. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
Kamieńska E
Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
[TBL] [Abstract][Full Text] [Related]
32. Treatment of pediatric non-Hodgkin lymphoma in Hungary: 15 years experience with NHL-BFM 90 and 95 protocols.
Müller J; Csóka M; Jakab Z; Ponyi A; Erlaky H; Kovács G
Pediatr Blood Cancer; 2008 Mar; 50(3):633-5. PubMed ID: 17366531
[TBL] [Abstract][Full Text] [Related]
33. [Radiotherapy of primary extranodal non-Hodgkin's lymphoma of the head and neck region. Results of a prospective multicenter study. Study Group NHL: early studies].
Hoederath A; Sack H; Stuschke M; Lampka E
Strahlenther Onkol; 1996 Jul; 172(7):356-66; discussion 367-8. PubMed ID: 8693402
[TBL] [Abstract][Full Text] [Related]
34. [Clinical characteristics and treatment outcome of 36 cases with non-Hodgkin's lymphoma arising from mediastinum in children].
Tang YJ; Tang JY; Pan C; Xue HL; Chen J; Shen SH; Dong L; Zhou M; Wang YP; Gu LJ; Jiang H; Ye QD
Zhonghua Er Ke Za Zhi; 2009 Sep; 47(9):687-90. PubMed ID: 20021793
[TBL] [Abstract][Full Text] [Related]
35. Treatment of children and adolescents with non-Hodgkin's lymphoma (results based on the NHL Berlin-Frankfurt-Münster 90 protocols).
Kavan P; Kabicková E; Gajdos P; Koutecký J; Smelhaus V; Stanková J; McClain KL
Cas Lek Cesk; 1999 Jan; 138(2):40-6. PubMed ID: 10376402
[TBL] [Abstract][Full Text] [Related]
36. [Treatment outcome of non-Hodgkin lymphoma in childhood: KYCCSG NHL-89, 96].
Fukano R; Suminoe A; Matsuzaki A; Inada H; Nagatoshi Y; Ishii E; Nakayama H; Kawakami K; Moritake H; Yanai F; Itonaga N; Suenobu S; Kikuchi M; Okamura J; Kawano Y
Rinsho Ketsueki; 2012 Nov; 53(11):1898-905. PubMed ID: 23257670
[TBL] [Abstract][Full Text] [Related]
37. [Studies of childhood non-Hodgkin's lymphoma--treatment results with the CCLSG NHL 960 protocol. Children's Cancer and Leukemia Study Group (CCLSG)].
Tsurusawa M; Katano N; Hirota T; Ito M; Yanase T; Asami K; Koizumi S; Nakayama M; Miyawaki T; Suzumiya J; Nishikawa K; Mugisima H; Horikoshi Y; Hatae Y; Iwai A; Anami K; Kikuchi M; Osima K; Kaneko Y; Kataoka S; Tanaka A; Chin M; Taga T; Watanabe A; Fujimoto T
Rinsho Ketsueki; 1998 Nov; 39(11):1092-8. PubMed ID: 9866420
[TBL] [Abstract][Full Text] [Related]
38. CD20 positive childhood B-non Hodgkin lymphoma (B-NHL): morphology, immunophenotype and a novel treatment approach: a single center experience.
Bilić E; Femenić R; Konja J; Simat M; Dubravcić K; Batinić D; Ries S; Rajić L
Coll Antropol; 2010 Mar; 34(1):171-5. PubMed ID: 20432747
[TBL] [Abstract][Full Text] [Related]
39. Impact of three courses of intensified CHOP prior to high-dose sequential therapy followed by autologous stem-cell transplantation as first-line treatment in poor-risk, aggressive non-hodgkin's lymphoma: comparative analysis of Dutch-Belgian Hemato-Oncology Cooperative Group Studies 27 and 40.
van Imhoff GW; van der Holt B; Mackenzie MA; Van't Veer MB; Wijermans PW; Ossenkoppele GJ; Schouten HC; Sonneveld P; Steijaert MM; Kluin PM; Kluin-Nelemans HC; Verdonck LF;
J Clin Oncol; 2005 Jun; 23(16):3793-801. PubMed ID: 15809447
[TBL] [Abstract][Full Text] [Related]
40. Outcome of children with primary resistant or relapsed non-Hodgkin lymphoma and mature B-cell leukemia after intensive first-line treatment: a population-based analysis of the Austrian Cooperative Study Group.
Attarbaschi A; Dworzak M; Steiner M; Urban C; Fink FM; Reiter A; Gadner H; Mann G
Pediatr Blood Cancer; 2005 Jan; 44(1):70-6. PubMed ID: 15368550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
